Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and IIScott Evans, Robert A. Bonomo, David J. Ecker et al.|Clinical Infectious Diseases|2015Cited by 61
Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological DysfunctionKevin R. Robertson, Colin D. Hall, Bibilola Oladeji et al.|Clinical Infectious Diseases|2018Cited by 18
LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in GliomaFei Shi, Hongyu Jiang|Journal of Oncology|2023Cited by 3
608Can Rapid Molecular Diagnostics Assist in the Choice of b-Lactam Antibiotics? An Analysis of Data from PRIMERS-II of the Antibiotic Resistance Leadership Group (ARLG)Andrea M. Hujer, Robert A. Bonomo, Scott Evans et al.|Open Forum Infectious Diseases|2014Cited by 1